APA (7th ed.) Citation

R, M., M, A., S, K., MS, K., SAM, A., M, S., . . . L, F. (2025). The recombinant anti-MET/EpCAM bispecific antibody fragment: A promising novel therapeutic approach for breast cancer treatment. Investigational new drugs, 43(3), 687. https://doi.org/10.1007/s10637-025-01546-3

Chicago Style (17th ed.) Citation

R, Mirzaei, Azimi M, Karimi S, Karimi MS, Aghel SAM, Salehi M, Jalili N, Yadegari F, and Farahmand L. "The Recombinant Anti-MET/EpCAM Bispecific Antibody Fragment: A Promising Novel Therapeutic Approach for Breast Cancer Treatment." Investigational New Drugs 43, no. 3 (2025): 687. https://doi.org/10.1007/s10637-025-01546-3.

MLA (9th ed.) Citation

R, Mirzaei, et al. "The Recombinant Anti-MET/EpCAM Bispecific Antibody Fragment: A Promising Novel Therapeutic Approach for Breast Cancer Treatment." Investigational New Drugs, vol. 43, no. 3, 2025, p. 687, https://doi.org/10.1007/s10637-025-01546-3.